Summary
GlobalData has released its pharma report, “Seasonal Influenza Vaccines - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Seasonal Influenza Vaccines Market. The report identifies and analyses the key companies shaping and driving the global Seasonal Influenza Vaccines market. The report provides insight into the competitive Seasonal Influenza Vaccines landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.
*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.
Scope
- Investigation of current and future market competition for Seasonal Influenza Vaccines
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Seasonal Influenza Vaccines sector through market impact analysis, future market scenario and company analysis
Reasons to buy
- Gain a high level view of the trends shaping and driving Seasonal Influenza Vaccines market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Seasonal Influenza Vaccines market landscape? Identify, understand and capitalize
Companies Mentioned
Sanofi
CSL Limited (Seqirus)
GlaxoSmithKline
AstraZeneca (MedImmune)
Protein Sciences Corporation
Mitsubishi Tanabe Pharma
Novavax
Mylan
Daiichi Sankyo
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Catalyst 5
2.2 Related Reports 6
2.3 Upcoming Related Reports 6
3 Market Outlook 7
3.1 Global Markets 7
3.1.1 Forecast 7
3.1.2 Drivers and Barriers - Global Issues 13
4 Current and Future Players 14
4.1 Overview 14
4.2 Trends in Corporate Strategy 18
4.3 Company Profiles - Major Players 21
4.3.1 Sanofi 21
4.3.2 CSL Limited (Seqirus) 23
4.3.3 GlaxoSmithKline 25
4.3.4 AstraZeneca (MedImmune) 26
4.3.5 Protein Sciences Corporation 29
4.3.6 Mitsubishi Tanabe Pharma 31
4.3.7 Novavax 32
4.4 Other Companies 34
4.4.1 Mylan 34
4.4.2 Daiichi Sankyo 35
5 Appendix 36
5.1 Bibliography 36
5.2 Abbreviations 74
5.3 Methodology 78
5.4 Forecasting Methodology 78
5.4.1 Vaccine Coverage 78
5.4.2 Vaccines Included 79
5.4.3 Key Launch Dates 79
5.4.4 Influenza Vaccine Tender System Assumptions 80
5.4.5 General Pricing Assumptions 81
5.4.6 Individual Vaccine Assumptions 82
5.4.7 Pricing of Pipeline Agents 90
5.5 Primary Research - KOLs Interviewed for this Report 91
5.6 Primary Research - Prescriber Survey 94
5.7 About the Authors 95
5.7.1 Analyst 95
5.7.2 Therapy Area Director 95
5.7.3 Epidemiologists 96
5.7.4 Director of Epidemiology 97
5.7.5 Global Director of Therapy Analysis and Epidemiology 97
5.8 About GlobalData 98
5.9 Disclaimer 98
1.1 List of Tables
Table 1: Global (7MM) Sales Forecasts ($m) for Seasonal Influenza Vaccines, 2015-2025 10
Table 2: Seasonal Influenza Vaccines Market - Drivers and Barriers, 7MM, 2015-2025 13
Table 3: Key Companies in the Seasonal Influenza Vaccines Market, 2016 17
Table 4: Sanofi’s Seasonal Influenza Vaccine Portfolio Assessment, 2016 22
Table 5: CSL Limited’s Seasonal Influenza Vaccine Portfolio Assessment, 2016 24
Table 6: GSK’s Seasonal Influenza Vaccine Portfolio Assessment, 2016 26
Table 7: AstraZeneca’s Seasonal Influenza Vaccine Portfolio Assessment, 2016 28
Table 8: Protein Sciences Corporation’s Seasonal Influenza Vaccine Portfolio Assessment, 2016 30
Table 9: Mitsubishi’s Seasonal Influenza Vaccine Portfolio Assessment, 2016 32
Table 10: Novavax’s Seasonal Influenza Vaccine Portfolio Assessment, 2016 34
Table 11: Key Launch Dates 80
Table 12: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 94
1.2 List of Figures
Figure 1: Global (7MM) Sales for Seasonal Influenza Vaccines by Country, 2015 and 2025 12
Figure 2: Company Portfolio Gap Analysis in Seasonal Influenza Vaccines, 2015-2025 18
